CCK-AR Antibody (377251) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2680JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG2A Clone # 377251
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human CCK‑A R
Met1-Gln428
Accession # P32238
Met1-Gln428
Accession # P32238
Specificity
Detects human CCK‑A R. Stains human CCK-A R transfectants but not irrelevant transfectants.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for CCK-AR Antibody (377251) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCK-AR
Long Name
Cholecystokinin Receptor, Type A
Alternate Names
CCK-A R, CCK1R, CCKAR
Gene Symbol
CCKAR
Additional CCK-AR Products
Product Documents for CCK-AR Antibody (377251) [Janelia Fluor® 635]
Product Specific Notices for CCK-AR Antibody (377251) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...